| |
|
|
|
CfPA-The Center for Professional Advancement, Amsterdam, The Netherlands
20-22 March 2019
Who Should Attend?
This course is designed for a broad range of pre-clinical, clinical, management, investment, and regulatory personnel in both established and emerging pharmaceutical and biological companies.
It will be of special value to:
• Scientists who wish to gain an understanding of pharmaceutical
toxicity studies
• Safety professionals
• Regulatory personnel
• Managerial personnel
• Early clinical project management staff
• Regulatory scientist involved in preclinical development
• Investors
• Anyone interested in preclinical toxicology studies Course Description
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
 Michelleanne Bradley, President, Metis Consulting Services Inc. |
Michelleanne Bradley is President of Metis Consulting Services Inc. She has over 15 years of experience in the Biotech and Pharmaceutical Industries. Ms Bradley has started drug safety departments for small organizations, acquisition integration for midsized organizations, and implementation with large organizations.
Ms Bradley is currently a pharmacovigilance and quality assurance consultant, performing site, company, and vendor audits, gap analysis, and oversight of drug safety database implementation. She has extensive experience with FDA and EMA audits and is a named consultant with a testing lab in the San Diego area. She is a graduate of the University of Georgia, Athens GA.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
Jmorbit@cfpa.com
|
|
|
|
|
|
|
|
|